Navigation Links
Data shows VisionGate's 3D imaging platform accurately detects lung cancer in sputum
Date:10/28/2013

Sydney, Australia and Phoenix, AZ, USA October 28, 2013 VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today reported clinical data showing that its automated 3D cell imaging platform, the Cell-CT, can detect lung cancer in sputum samples with high sensitivity and specificity. The data was presented at the International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer.

The pilot study analyzed sputum samples from patients with confirmed lung cancer and from healthy individuals. The results show that VisionGate's Cell-CT platform and LuCED sputum test accurately detected the presence or absence of lung cancer cells in patient sputum from a spontaneous cough. In the 53 individuals studied to date, LuCED and the Cell-CT achieved a sensitivity of more than 95% and specificity of 99.8%. The high sensitivity indicates that the Cell-CT detects most cancers, and the high specificity means that the rate of false positive readings is exceedingly low. This is far greater accuracy than has been demonstrated with any other lung cancer screening test.

"Lung cancer remains the leading cause of cancer death in the U.S., primarily because it is not detected until after the cancer has spread," commented Alan Nelson, Ph.D., Founder and CEO of VisionGate. "Results to date from this ongoing clinical study suggest that LuCED and the Cell-CT correctly identify more than nine out of every ten cases of lung cancer with virtually no false positive results, supporting the goal of developing a new lung cancer screening paradigm that is both accurate and cost-effective."

The automated Cell-CT platform creates strikingly clear and comprehensive 3D digital images of the cells contained in sputum. It uses advanced algorithms to identify the presence or absence of cell biosignatures associated with malignant or normal status, making it possible to determine with
'/>"/>

Contact: Barbara Lindheim
blindheim@bllbiopartners.com
917-355-9234
BLL Partners, LLC
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Wellesley study shows income inequality a key factor in high US teen births
2. Invasive heart test being dramatically overused, Stanford study shows
3. Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment
4. Lung Cancer Screening Might Pay Off, Analysis Shows
5. Nonsurgical Method to Measure Brain Pressure Shows Promise
6. BMC study shows diverting passengers to elevators could help reduce falls at Logan Airport
7. Study Shows New Option for Kids With Tough-to-Treat Leukemia
8. Politics May Get in the Way of Empathy, Research Shows
9. Live imaging shows response to cancer drugs can be boosted by altering tumor microenvironment
10. Experimental Pill for Multiple Sclerosis Shows Promise
11. Mechanical tissue resuscitation technology shows promise
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Data shows VisionGate's 3D imaging platform accurately detects lung cancer in sputum
(Date:7/2/2015)... PEACHTREE CITY, GA (PRWEB) , ... July 02, ... ... or field sporting the newest shades of the SIGVARIS PERFORMANCE SOCKS. Since the ... physicians, fitness experts and athletic trainers. Their significant popularity has inspired four new, ...
(Date:7/2/2015)... Md. (PRWEB) , ... July 02, 2015 , ... Six ... in his solo cross-country walk to raise awareness and money for the Pulmonary ... expects to arrive at PHA’s headquarters near Washington, D.C. by mid-September. He left Glasgow, ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ActiveBunch.com recently ... passion for social fitness. Built to function as a lifestyle community, Active Bunch allows ... the opportunity to network, meet, and participate in discussions or group events. , ...
(Date:7/2/2015)... (PRWEB) , ... July 02, ... ... wound therapy (NPWT) - pipeline review 2015” provides comprehensive information on the ... development. Complete report on negative pressure wound therapy (NPWT) with 22 market ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... announced today that it has reached an agreement to acquire eRubbermaid.com, an ... largest distributor of Rubbermaid Commercial Products on the web today. ...
Breaking Medicine News(10 mins):Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3Health News:ActiveBunch.com Launches as a Social Community for People with Active Lifestyles 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:CleanItSupply.com Acquires eRubbermaid.com 2
... modified strain, has led to the death of a 27-week-old ... mature babies are undergoing treatment. ,The babies are ... they were found to be carriers of Panton-Valentine Leukocidin (PVL) ... ,Hospital authorities have confirmed that the baby died due to ...
... PLoS Medicine, doctors report on the case of a ... accident and emergency department //with double vision, slurred speech, ... out to be wound botulism. ,Wound botulism is ... the bacterium Clostridium botulinum contaminate a wound, germinate, and ...
... Kerala promises heavy investment opportunities for Non-Resident Keralites (NRK), ... the// long term. ,Kerala Tourism Department ... March 23 – 27 for showcasing the opportunities in ... be a congregation of major hospitals, health insurance companies, ...
... and Drug Administration (FDA) will release its approval for consumption ... ,Two federal scientists, Larisa Rudenko and John C. ... and milk of cloned animals and their offspring. “On no ... animals from normal animals,” they say. ,A formal ...
... suffer at the Patna Medical College and Hospital (PMCH) ... strike demanding security, despite assurances from the Bihar government. ... an alleged attack on some of them by attendants ... Rai gave an assurance to fulfil their demands, Vinod ...
... reduced the use of illicit drugs, but have got ... opine. , ,The MTF survey has been the ... since 1975. The most recent survey, collating information from ... classes eighth, 10th and 12th grades has revealed that ...
Cached Medicine News:
(Date:7/2/2015)... VANCOUVER , July 2, 2015 /PRNewswire/ - ESSA Pharma ... its common shares have been approved for listing and trading ... ESSA will begin trading on NASDAQ on July ... TSX Venture Exchange under the symbol "EPI". As ... the NASDAQ, each of the Company,s outstanding special warrants issued ...
(Date:7/2/2015)... , July 2, 2015  Fort Lauderdale-based ... pleased to announce that its Consumer Group completed ... to Kerry Group plc (ISE: KRZ) ("Kerry"), one ... and nutrition systems, as well as functional ingredients ... pharmaceutical markets. Farlie Turner served as the exclusive ...
(Date:7/2/2015)... , July 2, 2015 Roche,s ... conspicuously high-growth market segment in hematology testing, according ... said that Roche,s recent unveiling of its Bloodhound digital ... cobas m 511 hematology analyzer – ... capture growth enjoyed by current leader CellaVision, but ...
Breaking Medicine Technology:ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3
... Nov. 11, 2010 Applied Precision, a leader in life ... four of its revolutionary DeltaVisio n OMX® ... weeks. The Delta V ision ... than doubles the optical resolution of the traditional light microscope ...
... Reata Pharmaceuticals today announced that the company will present ... clinical trial of bardoxolone methyl in patients with ... The data will be presented in a late-breaking oral presentation ... Conference to be held November 16-21, 2010, in Denver, ...
Cached Medicine Technology:Applied Precision Installs a Record Four New DeltaVision OMX Super-Resolution Imaging Systems in Eight Weeks 2Reata Pharmaceuticals to Present Data from Pivotal Phase 2b Trial in Type 2 Diabetics With Chronic Kidney Disease 2Reata Pharmaceuticals to Present Data from Pivotal Phase 2b Trial in Type 2 Diabetics With Chronic Kidney Disease 3
Non-dissolvable Herrick Lacrimal Plugs provide long-term lacrimal occlusion through partial blockage of the horizontal canaliculus....
... Patients who need punctal occlusion ... eye relief. They also want ... as comfortable and as unobtrusive ... Alcon punctal plugs are growing ...
10 (mm) smooth platform; Serrated handle in stainless steel....
... Only Heartlab delivers the performance ... cardiovascular information management systems. As ... and services set the benchmark. ... functionality, high-speed performance and technological ...
Medicine Products: